Naloxone activation of μ-opioid receptors mutated at a histidine residue lining the opioid binding cavity

Molecular Pharmacology

Volumn 52, Issue 6, 1997, Pages 983-992

  Spivak, Charles E ^a   Beglan, Carol L ^a   Seidleck, Brian K ^a   Hirshbein, Laura D ^a   Blaschak, Carrie J ^a   Uhl, George R ^a   Surratt, Christopher K ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; MU OPIATE RECEPTOR; NALOXONE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONFORMATIONAL TRANSITION; DRUG RECEPTOR BINDING; FEMALE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN CONFORMATION; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; SECOND MESSENGER; SITE DIRECTED MUTAGENESIS; XENOPUS LAEVIS;

EID: 0031440123     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.6.983     Document Type: Article

References (40)

1. Evans, C. J., D. E. Keith, H. Morrison, K. Magendzo, and R. H. Edwards. Cloning of a delta opioid receptor by functional expression. Science (Washington D. C.) 258:1952-1955 (1992).
2. Kieffer, B. L., K. Befort, C. Gaveriaux-Ruff, and C. G. Hirth. The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 89:12048-12052 (1992).
3. Wang, J. B., Y. Imai, C. M. Eppler, P. Gregor, C. E. Spivak, and G. R. Uhl. μ Opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. USA 90:10230-10234 (1993).
4. Chen, Y., A. Mestak, J. Liu, J. A. Hurley, and L. Yu. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44:8-12(1993).
5. Fukuda, K., S. Kato, K. Mori, M. Nishi, and H. Takeshima. Primary structures and expression from cDNAs of rat opioid receptor δ-and μ-subtypes. FEBS Lett. 327:311-314 (1993).
6. Thompson, R. C., A. Mansour, H. Akil, and S. J. Watson. Cloning and pharmacological characterization of a rat μ opiate receptor. Neuron 11: 903-913 (1993).
7. Yasuda, K., K. Raynor, H. Kong, C. Breder, J. Takeda, T. Reisine, and G. I. Bell. Cloning and functional comparison of κ and δ opioid receptors from mouse brain. Proc. Natl. Acad. Sci. USA 90:6736-6740 (1993).
8. Knapp, R. J., E. Malatynska, L. Fang, X. Li, E. Babin, M. Nguyen, G. Santoro, E. V. Varga, V. J. Hruby, W. R. Roeske, and H. I. Yamamura. Identification of a human delta opioid receptor: cloning and expression. Life Sci. 54:463-469 (1994).
9. 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. Mol. Pharmacol. 40:168-179 (1991).
10. Fraser, C. M., C. D. Wang, D. A. Robinson, J. D. Gocayne, and J. C. Venter. Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: conserved aspartic acids play important roles in receptor function. Mol. Pharmacol. 36:840-847 (1989).
11. Strader, C. D., I. S. Sigal, M. R. Candelore, E. Rands, W. S. Hill, and R. A. F. Dixon. Conserved aspartic acid residues 79 and 113 of the β-adrenergic receptor have different roles in receptor function. J. Biol. Chem. 263:10267-10271 (1988).
12. Trumpp-Kallmeyer, S., J. Hoflack, A. Bruinvels, and M. Hibert. Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. J. Med. Chem. 35: 3448-3462 (1992).
13. Savarese, T. M., and C. M. Fraser. In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem. J. 283:1-19 (1992).
14. Surratt, C. K., P. S. Johnson, A. Moriwaki, B. K. Seidleck, C. J. Blaschak, J. B. Wang, and G. R. Uhl. μ Opiate receptor: charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J. Biol. Chem. 269:20548-20553 (1994).
15. Henderson, R., J. M. Baldwin, T. A. Ceska, F. Zemlin, E. Beckmann, and K. H. Downing. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J. Mol. Biol. 213:899-929 (1990).
16. Henderson, R., and G. F. X. Schertler. The structure of bacteriorhodopsin and its relevance to the visual opsins and other seven-helix G-protein coupled receptors. Phil. Trans. R. Soc. Lond. B 326:379-389 (1990).
17. Schertler, G. F. X., C. Villa, and R. Henderson. Projection structure of rhodopsin. Nature (Lond.) 362:770-772 (1993).
18. Thirstrup, K., C. E. Elling, S. A. Hjorth, and T. W. Schwartz. Construction of a high affinity zinc switch in the κ-opioid receptor. J. Biol. Chem. 271:7875-7878 (1996).
19. Strader, C. D., T. M. Fong, M. R. Tota, and D. Underwood. Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63:101-132 (1994).
20. Munson, P. J., and D. Rodbard. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Analy. Biochem. 107:220-239 (1980).
21. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:3099-3102 (1973).
22. + channel: expression cloning and molecular properties. Proc. Natl. Acad. Sci. USA 90: 10235-10239 (1993).
23. Nestler, E. J., J. J. Erdos, R. Terwilliger, R. S. Duman, and J. F. Tallman. Regulation of G proteins by chronic morphine in the rat locus coeruleus. Brain Res. 476:230-239 (1989).
24. Padan, E., L. Patel, and H. R. Kaback. Effect of diethylpyrocarbonate on lactose/proton symport in Escherichia coli membrane vesicles. Proc. Natl. Acad. Sci. USA 76:6221-6225 (1979).
25. Shahrestanifar, M., W. W. Wang, and R. D. Howells RD. Studies on inhibition of μ and δ opioid receptor binding by dithiothreitol and N-ethylmaleimide. J. Biol. Chem. 271:5505-5512 (1996).
26. North, R. A., J. T. Williams, A. Surprenant, and M. J. Christie. Mμ and delta receptors belong to a family of receptors that are coupled to potassium channels. Proc. Natl. Acad. Sci. USA 84:5487-5491 (1987).
27. Martin, W. R., C. G. Eades, J. A. Thompson, R. E. Huppler, and P. E. Gilbert. The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:517-532 (1976).
28. Creighton, T. E. Proteins, Structures and Molecular Properties. W. H. Freeman and Co., New York, NY, 1993.
29. Wimpey, T. L., and C. Chavkin. Opioids activate both an inward rectifier and a novel voltage-gated potassium conductance in the hippocampal formation. Neuron 6:281-289 (1991).
30. DiChiara, G, and R. A. North. Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13:185-193 (1992).
31. Claude, P. A., D. R. Wotta, X. H. Zhang, P. L. Prather, T. M. McGinn, L. J. Erickson, H. H. Loh, and P. Y. Law. Mutation of a conserved serine in TM 4 of opioid receptors confers full agonistic properties to classical antagonists. Proc. Natl. Acad. Sci. USA 93:5715-5719 (1996).
32. Xue, J. C., C. Chen, J. Zhu, S. Kunapuli, J. K. DeRiel, L. Yu, and L. Y. Liu-Chen. Differential binding domains of peptide and non-peptide ligands in the cloned rat κ opioid receptor. J. Biol. Chem. 269:30195-30199.
33. Minami, M., T. Onogi, T. Nakagawa, Y. Katao, Y. Aoki, S. Katsumata, and M. Satoh. DAMGO, a μ-opioid receptor selective ligand, distinguishes between μ-and κ-opioid receptors at a different region from that for the distinction between μ-and δ-opioid receptors. FEBS Lett. 364:23-27 (1995).
34. Meng, F., M. T. Hoversten, R. C. Thompson, L. Taylor, S. J. Watson, and H. Akil. A chimeric study of the molecular basis of affinity and selectivity of the κ and the δ opioid receptors. J. Biol. Chem. 270:12730-12736 (1995).
35. Chen, C., J. C. Xue, J. Zhu, Y. W. Chen, S. Kunapuli, J. K. de Riel, L. Yu, and L. Y. Liu-Chen. Characterization of irreversible binding of β-funaltrexamine to the cloned rat μ opioid receptor. J. Biol. Chem. 270: 17866-17870 (1995).
36. 3H] β-funaltrexamine covalent binding in the cloned rat μ opioid receptor. J. Biol. Chem. 271:21422-21429 (1996).
37. Fukuda, K., S. Kato, and K. Mori. Location of regions of the opioid receptor involved in selective agonist binding. J. Biol. Chem. 270:6702-6709 (1995).
38. Fong, T. M., H. Yu, M. A. Cascieri, D. Underwood, C. J. Swain, and C. D. Strader. The role of histidine 265 in antagonist binding to the neurokinin-1 receptor. J. Biol. Chem. 269:2728-2732 (1994).
39. 2 dopamine receptors: mutation of a histidine residue specifically affects the binding of a subgroup of substituted benzamide drugs. J. Neurochem. 62:1664-1669 (1994).
40. Schambye, H. T., S. A. Hjorth, J. Weinstock, and T. W. Schwartz. Interaction between the nonpeptide angiotensin antagonist SKF-108,566 and histidine 256 (HisVI:16) of the angiotensin type 1 receptor. Mol. Pharmacol. 47:425-431 (1995).